Cargando…

Correction: Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316411/ https://www.ncbi.nlm.nih.gov/pubmed/32581047 http://dx.doi.org/10.1136/jitc-2020-000676corr1

Ejemplares similares

Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
por: Stüber, Tanja, et al.
Publicado: (2020)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Correction: Characterization of Negative Feedback Network Motifs in the TGF-β Signaling Pathway
por: Nicklas, Daniel, et al.
Publicado: (2014)

Correction: Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
por: Zhang, Zhiwei, et al.
Publicado: (2020)

Correction: an embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma
por: Ehira, Nobuyuki, et al.
Publicado: (2014)

Correction: Curcumin Inhibits CD4(+) T Cell Activation, but Augments CD69 Expression and TGF-β1-Mediated Generation of Regulatory T Cells at Late Phase
por: Kim, Girak, et al.
Publicado: (2013)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma
por: Schiavone, Giovanna, et al.
Publicado: (2020)

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Publicado: (2014)

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
por: Dituri, Francesco, et al.
Publicado: (2013)

Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer
por: Fatima, Iram, et al.
Publicado: (2018)

Correction: TGF-β Prevents Phosphate-Induced Osteogenesis through Inhibition of BMP and Wnt/β-Catenin Pathways
Publicado: (2014)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Correction: TGFβ-activation by dendritic cells drives Th17 induction and intestinal contractility and augments the expulsion of the parasite Trichinella spiralis in mice
por: Steel, Nicola, et al.
Publicado: (2021)

Correction: The Self-Limiting Dynamics of TGF-β Signaling In Silico and In Vitro, with Negative Feedback through PPM1A Upregulation
Publicado: (2014)

Anti-ROR1 CAR-T cells: Architecture and performance
por: Osorio-Rodríguez, Daniel Andrés, et al.
Publicado: (2023)

Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies
por: Lee, Boon kiat, et al.
Publicado: (2022)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Correction to: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

Correction: Genetic dissection of main and epistatic effects of QTL based on augmented triple test cross design
por: Zhang, Xueli, et al.
Publicado: (2018)

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
por: Kim, Eunju, et al.
Publicado: (2022)

Correction for: Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway
por: Zhang, Yu, et al.
Publicado: (2022)

Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
por: Li, You, et al.
Publicado: (2020)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
por: Elnaggar, Muhammad, et al.
Publicado: (2023)

Correction: Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Publicado: (2023)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
por: Xue, Xiaohua, et al.
Publicado: (2022)

Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway
por: Hou, LingLi, et al.
Publicado: (2018)

Pirfenidone suppressed triple‐negative breast cancer metastasis by inhibiting the activity of the TGF‐β/SMAD pathway
por: Luo, Daiqin, et al.
Publicado: (2023)

Correction to: MSX2 suppression through inhibition of TGFβ signaling enhances hematopoietic differentiation of human embryonic stem cells
por: Wang, Hongtao, et al.
Publicado: (2020)

Author Correction: The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis
por: Chang, Che-Chang, et al.
Publicado: (2020)

Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
Publicado: (2020)

Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
por: Fang, Chi, et al.
Publicado: (2021)

Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
por: Hu, Biliang, et al.
Publicado: (2017)

Correction for: Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition
por: Qiu, Chan, et al.
Publicado: (2019)

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors
por: Necela, Brian M., et al.
Publicado: (2015)

Correction: WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2021)

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
por: Jank, Paul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eis5l7oqgjo087bsfbvsij3m1l